🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

JPMorgan stock holds overweight rating with strong performance in equity markets

EditorAhmed Abdulazez Abdulkadir
Published 10/09/2024, 18:02
© Reuters.
JPM
-


On Tuesday, Barclays (LON:BARC) reaffirmed its positive stance on JPMorgan Chase & Co. (NYSE:JPM), maintaining an Overweight rating and a price target of $217.00. The bank's third quarter of 2024 is showing promising signs, with investment banking fees expected to rise by approximately 15% year-over-year, propelled by robust Debt Capital Markets (DCM) activity.


JPMorgan forecasts that volumes in institutional loans and leveraged loans will nearly double compared to the same period last year. Equity Capital Markets (ECM) activity remains strong, while mergers and acquisitions (M&A) are anticipated to stay relatively stable.


JPMorgan has projected its third-quarter trading revenue for 2024 to be flat or possibly increase by up to 2%, citing strength in equities, especially derivatives, which is expected to balance out weaker Fixed Income, Currencies, and Commodities (FICC) trading, particularly in rates. The bank also reiterated its Net Interest Income (NII) expectation of around $91 billion for 2024, while suggesting that the consensus NII forecast of $90 billion for 2025 might be overly optimistic due to lower rate projections and asset sensitivity.


The financial institution has also maintained its 2024 expense guidance, excluding firmwide legal expenses, at approximately $92 billion. This includes additional costs from the Federal Deposit Insurance Corporation (FDIC) special assessment in the first quarter of 2024 and a Foundation contribution in the second quarter.


However, JPMorgan anticipates that the consensus expense estimate of about $93.7 billion for 2025 may fall short, expecting actual expenses to be higher due to new investments in areas such as artificial intelligence, data centers, and application refactoring.


For credit card net charge-off (NCO) rates, JPMorgan continues to expect a rate of around 3.40% for 2024, with a slight increase to approximately 3.60% for 2025. Despite potential medium-term increases in delinquencies, the bank remains within its underwriting expectations. Observations on the U.S. economy indicate that consumption is still present, with non-discretionary spending growing, albeit at a slower rate. JPMorgan notes that while excess savings from the Covid period are largely depleted, the cash buffer remains above historical averages due to wages rising faster than inflation.


JPMorgan is confident in its ability to deliver a return on tangible common equity (ROTCE) of 17% over the cycle, although it acknowledges that reaching this target in 2025 could be more challenging. The bank also foresees a modest pace of buybacks due to uncertainties surrounding Basel III finalization (B3E) regulations.


JPMorgan has evolved its corporate structure with the creation of the Commercial & Investment Bank (CIB), which amalgamates major wholesale businesses to form a larger platform aimed at increasing market share and serving a broader client base. In its consumer business, JPMorgan is targeting a 15% share of total U.S. deposits over time, up from its current share of approximately 11.5%, and aims to increase its card market share to 20% from the current 17%, through expansion and investment in areas like travel and connected commerce.


In other recent news, JPMorgan has been the subject of recent analyst evaluations and regulatory investigations. Financial firm Piper Sandler has maintained its Overweight rating on JPMorgan shares, citing the bank's strong position amid challenges faced by competitors. The firm also expects investors to closely follow management's remarks on consumer health and other key business dynamics during JPMorgan's mid-quarter update.


Conversely, Deutsche Bank (ETR:DBKGn) has downgraded JPMorgan's stock from Buy to Hold, attributing this change to the bank's year-to-date performance and limited potential for further upside. Both firms have maintained their respective price targets.


In regulatory news, the Consumer Financial Protection Bureau (CFPB) is investigating JPMorgan and other major U.S. banks regarding the handling of customer funds on the Zelle Network (LON:NETW). In response to the CFPB's inquiries, JPMorgan is considering legal action against the bureau.


Major brokerages, including JPMorgan, are anticipating a Federal Reserve rate cut in September following a rise in the U.S. unemployment rate.

InvestingPro Insights


As JPMorgan Chase & Co. (NYSE:JPM) continues to navigate the financial landscape, InvestingPro data and tips offer additional context for investors. The bank's market capitalization stands strong at $616.86 billion, showcasing its significant presence in the industry. A notable InvestingPro Tip is that JPMorgan has raised its dividend for 13 consecutive years, reflecting a commitment to shareholder returns and financial stability. This is complemented by the bank's low price-to-earnings (P/E) ratio of 11.26, which, when adjusted for the last twelve months as of Q2 2024, is even lower at 10.48, suggesting that the stock may be undervalued relative to its near-term earnings growth.


Furthermore, the bank's revenue growth has been impressive, with a 19.08% increase over the last twelve months as of Q2 2024, and an even more substantial quarterly revenue growth of 31.75% in Q2 2024. These metrics, combined with a solid dividend yield of 2.12%, make JPMorgan an attractive prospect for those looking for both growth and income. For investors seeking a deeper dive into JPMorgan's performance and potential, there are additional InvestingPro Tips available, providing a comprehensive analysis of the bank's financial health and market position.


With 9 more InvestingPro Tips available, including insights on profitability and returns over various time frames, investors can gain a richer understanding of JPMorgan's market dynamics and future prospects. Visit InvestingPro for a full suite of analytical tools and expert tips tailored to JPMorgan's stock performance and potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.